Bad medicine: the way we manage diabetesBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f2695 (Published 29 April 2013) Cite this as: BMJ 2013;346:f2695
- Des Spence, general practitioner, Glasgow
Type 2 diabetes is a modern plague largely brought on by lifestyle and is considered a progressive, non-reversible condition. The polypharmacy of chronic disease is the drug industry’s lottery win, and no more so than in diabetes, with new drugs and the increasing use of analogue insulin in type 2 diabetes worth tens of billions of pounds worldwide.1 ⇑
The drug industry’s business plan for diabetes follows a familiar pattern:
(1) Conduct questionable research and control the original data.
(2) Schmooze the politicians, health regulators, and patient groups to suggest undertreatment and need for “urgent action.”
(3) Recruit tame diabetologists, massage …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial